Detalles de la búsqueda
1.
Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study.
J Infect Dis
; 225(9): 1513-1520, 2022 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32658250
2.
Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial.
Diabetes Obes Metab
; 19(8): 1127-1134, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28239939
3.
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.
J Infect Dis
; 213(10): 1562-72, 2016 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26704612
4.
Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial.
Hum Vaccin Immunother
; 16(10): 2456-2464, 2020 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32119591
5.
Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
J Pediatr
; 154(4): 514-520.e4, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19054529
6.
Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year.
Paediatr Drugs
; 10(4): 255-63, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18590344
7.
A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate.
Vaccine
; 36(27): 3976-3983, 2018 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29789238
8.
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study.
Vaccine
; 33(46): 6351-9, 2015 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26384447
9.
Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.
J Clin Endocrinol Metab
; 98(12): 4691-701, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24057294
Resultados
1 -
9
de 9
1
Próxima >
>>